Psidium guajava L. AS AN ALTERNATIVE FOR ANTI-INFLUENZA VIRUS: A REVIEW
Yedy Purwandi Sukmawan* and Hendy Suhendy
ABSTRACT
Background: As of March 11, 2020, the World Health Organization declared COVID-19 pandemic. More than one hundred countries were affected by this virus with 132.758 confirmed and 4955 death as March 13, 2020. Aim of the study: Much research was conducted to discover an effective drug. Lopinavir/ritonavir, ribavirin, interferon-?, chloroquine phosphate, and arbidol have been recommended for the treatment of this virus. However, no verified anti-viral for the treatment of this COVID-19. Psidium guajava L is one of the valuable of herbal medicine for the anti-influenza virus. Materials and Methods We conducted a systematic review with a search strategy involving PubMed and Cochrane. Results: Two article were met the inclusion criteria. This plant showed anti-influenza virus activity through many mechanisms of action. Conclusion: This broad mechanism of action involved in anti-influenza virus activity makes this plant a promising novel for this COVID-19 outbreak treatment.
[Full Text Article] [Download Certificate]